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Summary We investigated in the rat the role of the Apcgene, which is mutated in familial adenomatous polyposis and sporadic colon cancer
in the process leading from normal colonic mucosa to aberrant crypt foci (ACF) and finally to adenomas and adenocarcinomas. We analysed
mutations in exon 15 of the rat Apc gene using in vitro synthesized protein assay in 66 ACF and in 28 colon tumours induced by
azoxymethane. No Apc mutations were found in ACF, whereas five mutations were found in the tumours. The data suggest that mutations of
the Apc gene are associated with the transition from ACF to adenoma and adenocarcinoma and not from normal mucosa to ACF.
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According to current views, colon carcinogenesis is a multistep
process in which preneoplastic lesions accumulate in mucosa
cells, finally leading to neoplastic transformation (Kinzler and
Vogelstein, 1996). Many molecular events have been suggested to
play a role in the transition from normal colon mucosa to cancer,
such as the activation of oncogenes, the inactivation or loss of
tumour-suppressor genes and mutations in DNA repair genes
(Kinzler and Vogelstein, 1996). According to a commonly
accepted model of colorectal tumorigenesis, K-ras and APC
(adenomatous polyposis coli) gene mutations are early genetic
events (Kinzler and Vogelstein, 1996). The APC gene in mutated
in familial adenomatous polyposis (FAP) and in human sporadic
colon tumours with a frequency ranging from 40% to 80%
(Nakamura, 1993; De Benedetti et al, 1994; Kinzler and
Vogelstein, 1996). The humanAPC gene (exons 1-15) contains an
open reading frame of over 8500 nucleotides (Groden et al, 1991;
Kinzler et al, 1991) and encodes for a cytoplasmic protein of
300 kDa that binds to 3-catenin (Rubinfeld et al, 1996), suggesting
that APC product might regulate cell adhesion. About 50-60% of
the somatic mutations of the APC gene are clustered in a 700-bp
region, designated in humans as the mutation cluster region
(MCR) (Nakamura, 1993). More than 95% of the mutations in the
human APC gene are nonsense or frameshift mutations that result
in truncated proteins (Nakamura, 1993; Powell et al, 1993).
Aberrant crypt foci (ACF) have been suggested to be the first
preneoplastic lesions preceding the development ofadenomas and
carcinomas (Bird, 1987). ACF are easily induced in experimental
animals by a variety ofcarcinogens (Bird, 1987; Bruce et al, 1993)
and have been described in humans with sporadic colon cancer
and with familial adenomatous polyposis coli (Pretlow et al, 1991;
Roncucci et al, 1991). ACF have been widely used as end points in
experimental colon carcinogenesis (Bruce et al, 1993), although
some authors have not observed a correlation between ACF
formation and colon cancer (Hardmann et al, 1991).
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Azoxymethane (AOM), one of the most extensively studied
colon carcinogens, is able to induce both ACF and tumours in rats,
and AOM-induced colon carcinogenesis is a widely used model
for studying the multistage development of cancer (Ward et al,
1973; Reddy and Maeura, 1984).
The genetic characterization of AOM-induced colon cancers
and ACF has been carried out so far by focusing mainly on the
K-ras gene, which has been found mutated in cancers and also in
ACF with a frequency varying from 7% to 32% (Stopera et al,
1992; Vivona et al, 1993; Shivapurkar et al, 1994). However, no
information is available on the status of the Apc gene in this
experimental model in the rat.
Recently, the genomic structure of the Apc gene has also been
determined in rats (Kakiuchi et al, 1995). The rat Apc gene has a
high homology with human and mouse Apc (85.6% and 90.8% at
the nucleotide level and 90.4% and 92.9% at the amino acid level),
and Apc has been found mutated in tumours induced by the food
mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) or 2-
amino-1-methyl-6-phenylimdazo[4,5-b]pyridine (PhiP) (Kakiuchi
etal, 1995).
Given these considerations, we thought it was ofinterest to study
the Apc gene in ACF and in colonic tumours in order to investigate
its role in the transition from normal epithelium to ACF and from
ACF to adenoma and carcinoma in rats treated with AOM.
MATERIALS AND METHODS
Induction and identification of ACF and colonic
tumours
Male F344 rats (Nossan, Correzzana, Italy) were treated twice
subcutaneously, 1 week apart, with 15 mg kg-' AOM and sacri-
ficed between day 230 and day 245 after treatment. The colon was
washed with saline, opened longitudinally and observed without
formalin fixation under the microscope (40x magnification) to
identify ACF according to Bird (1987). ACF were then dissected
under a stereomicroscope and stored at - 80°C to be tested forApc
mutations. Serial sections of a few dissected ACF showed that no
more than 50% of a sample was made up of microscopically
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Table 1 Summary of the Apc mutations found in rat colon tumours induced by AOM
Tumour Histology Nucleotidea Nucleotide Result Length of
identification change truncated product
(kDa)
8-1a Tubular adenoma 3338 CAA-*TAA Gln-*Stop 50
95-1a Tubular adenoma 3245 CAA-JAA Gln->Stop 49
95-1a Tubular adenoma 3835 TAC-TAG Tyr->Stop 41
67-1 b Adenocarcinoma 3323 CAG-TAG Gln->Stop 50
B1 ND 3173 CAG-TAG Gln-*Stop 44
aNuclectide numbers are assigned according to the rat Apc cDNA sequence (Kakiuchi et al, 1995). ND, not determined.
normal mucosa. Macroscopic tumours located in the colon were
identified, dissected and divided into two equal parts. One was
stored at - 80°C to be tested for Apc mutations and one was fixed
in buffered formalin and stained with haematoxylin and eosin to be
analysed for histology.
Rats were maintained at a constant environmental temperature
of 22°C, with a 12-h light-dark cycle, according to internationally
accepted ethical guidelines for the treatment of experimental
animals (European Community, 1986).
DNA extraction
DNA was extracted from frozen ACF or tumours according to
Sambrook et al (1989).
In vitro synthezised protein assay (IVSP)
Analysis for mutations was performed using the polymerase chain
reaction (PCR) and the IVSP assay (Powell et al, 1993). A 2619 bp
region, between nucleotide (nt) 2131 and nt 4750 in exon 15 ofthe
gene, according to nucleotide numbers of the rat Apc cDNA
sequence (Kakiuchi et al, 1995), was amplified using three pairs of
primers. Three overlapping segments of the rat Apc (segment
A, from nt 2131 to nt 3564; segment B, from nt 2881 to nt
3938; segment C, from nt 3854 to nt 4750) were there-
fore amplified using the following primers and annealing tempera-
tures: segment A, 5'-GGATCCTAATACGACTCACTATA-
GGGAGACCACCATGGAGGAGGCTCTGTGGGACAT-3' and
5'-CATGGTGTTTCTCTTCATTA-3', 59°C; segment B,
5'-GGATCCTAATACGACTCACTATAGGGAGAC-
CACCATGGGGACATGCTCCATGCCTTATG-3' and
5'-AGAGTCTGCCTCCTGTGTTG-3', 61.5°C; segment C 5'-
GGATCCTAATACGACTCACTATAGGGAGACCACC-
ATGGGTTTCTCAAGGTGTAGTTCCT-3' and 5'-TCGGAAT-
CATCTAATAAGTC-3', 55°C. The PCRs were performed using
200 ng of genomic DNA, 350 ng each of the appropriate primers,
1.5 mm MgCl, and two units of Taq polymerase (Advanced
Biotechnologies, UK). Amplifications were performed in a thermal
cycler (Gene Amp PCR System 9600, Perkin Elmer, USA) for
35 cycles of 40-s denaturation (95°C), 90-s annealing and 120-s
(segment A), 60-s (segment B), 90-s (segment C) extension (72°C).
All PCRs included a 5-min extension period (72°C) after the 35th
cycle. PCR mixtures (2,l), purified with chloroform, were used as
templates in a linked transcription-translation system (T7-linked
transcription-translation system kit, Amersham, UK) containing
40 tCi of [35S]methionine (Amersham, UK) according to the
supplier's directions. Samples were diluted in sample buffer, boiled
for 5 min and analysed on 12.5% sodium dodecylsulphate-poly-
acrylamide gel. Proteins were visualized by autoradiography.
Detection ofApc mutations in diluted DNA samples was performed
by mixing PCR product (segment A) ofmutated DNA (tumour B1)
with the wild-type PCR product as follows: 1:1; 1:2; 1:5; 1:10;
1:20. These mixtures were used as templates for IVSP analysis.
Sequence analysis
PCR products for sequencing analysis were purified from agarose
gels (QlAquik gel extraction kit, Quiagen, Germany) and
sequenced using internal primers and the Circumvent Thermal
Cycle Dideoxy DNA Sequencing Kit (New England Biolabs, MA,
USA), following the manufacturer's protocol.
RESULTS
We analysed the rat Apc gene in 66 ACF (ranging in size from 2
to 21 aberrant crypts (AC), mean number of AC/ACF± s.e.:
10.32 ± 0.5), and in 28 colon tumours induced by AOM.
The IVSP analysis, performed on ACF of various sizes did not
show any mutations of the Apc gene. As the ACF also included
normal cells, besides those forming the focus and therefore
suspected to be tumour precursors, we tested the ability ofthe IVSP
assay to detect the occurrence of mutations, even if the mutated
gene was mixed with an excess amount of wild-type sequences.
This dilution experiment, carried out as described in Materials and
methods, showed that a truncated protein was still detectable after a
1:10 dilution with wild-type sequences (data not shown).
We also analysed the Apc gene in 28 tumours induced by AOM
(17 tubular adenomas, ten adenocarcinomas and one tumour
without histological characterization). We found three mutations
in the adenomas, one mutation in the adenocarcinomas and one
mutation in the tumour without histological characterization
(Table 1). Nucleotide sequence analysis (Table 1) showed that all
the mutations were single bp changes, resulting in stop codons.
One of the adenomas (sample 95-ia) showed two different muta-
tions (Table 1); because no wild-type band was detectable when
the IVSP was performed on the B region in this sample (data not
shown), it is possible that the two mutations were in two different
alleles.
The frequency of tumour samples (adenomas and adenocarci-
nomas) harbouring Apc mutations was 14.3%.
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DISCUSSION
In the present paper we investigated the role ofthe Apc gene in the
process leading from normal mucosa to ACF and finally to
adenomas and adenocarcinomas in the rat. Using the IVSP assay
we analysed mutations in a 2619-bp region of exon 15 of the Apc
gene in ACF and tumours.
Five Apc mutations were found in 28 tumours studied; all muta-
tions were single base substitutions: four transitions CG-4TA and
one transversion CG-*GC resulting in stop codons.
To ourknowledge, the status ofratApc gene during colon carcino-
genesis has been investigated in a single study (Kakiuchi et al, 1995),
in which colonic tumours were induced by the food carcinogens IQ
and PhiP. No data are available so far on Apc mutations in colon
carcinogensis induced by AOM in the rat, one of the experimental
models most used to study the evolution ofcolorectal cancer.
In our study we found that the frequency of tumour samples
harbouring Apc mutations was 14.3%. A similar value of Apc
mutation frequency (15.4%) was reported by Kakiuchi et al
(1995), in rats treated with IQ, whereas the same authors reported
a much higher frequency (62.5%) when rats were treated with
PhiP. In human colon tumours, the frequency of APC mutation
varies from 40% to 80% (Nakamura, 1993; De Benedetti et al,
1994; Kinzler and Vogelstein, 1996). We performed the genetic
analysis on a 2619-bp region ofexon 15 (from nt 2131 to nt 4750),
which also comprises the MCR, a 700-bp region most frequently
mutated in human sporadic colon cancer (Nakamura, 1993). It is
possible that analysis of a larger part of the Apc gene might have
detected a higher frequency of mutations. It is also possible that,
notwithstanding the high degree ofhomology between human and
rat Apc, the molecular events involved in the transition from
normal mucosa to cancer could be partially different in human and
rats or that the frequency found is dependent on the specific model
of rat AOM carcinogenesis.
In the present paper we also reported that no mutations were
found in the 66 ACF analysed. The number of ACF analysed was
reasonably high, making it unlikely that mutations were missed
because of small sampling size. In fact, although only a portion of
the Apc gene was analysed, we did find mutations in this same
region ofthe gene in adenomas and cancers.
Our results partially agree with those reported by Smith et al
(1994) who studied APC mutation in 65 human ACF derived from
FAP and sporadic colon cancer patients. In this study, in which a
1509-bp region was analysed, only 3 ACF out of 65 showed APC
mutations (4.6%). However, the three mutations found had the
same deletion and were all identified in ACF deriving from a
single FAP patient. Jen et al (1994), analysing a 3000-bp region of
exon 15, reported one APC mutation among 20 ACF harvested
from human colon. However, the single ACF, which was positive
forAPC mutation, presented a high level ofhistological dysplasia.
The histological classification of ACF in both humans and
experimental animals is a matter of debate (Bird et al, 1989; Bird
and Pretlow, 1992; Caderni et al, 1995; Otori et al, 1995). In our
study we did not evaluate the level of dysplasia in the ACF tested.
However, the ACF studied had variable dimensions and included a
certain number of lesions of larger size (11 ACF with 15 or more
AC). We previously demonstrated (Caderni et al, 1995) that mild
dysplastic characters (such as nuclear atypia, secretion of sialo-
mucins and luminal alterations) are progressively increased during
ACF growth. Similarly, Otori et al (1995) found a correlation
between crypt multiplicity and dysplasia, although they also found
large ACF with no signs ofdysplasia. It has also been reported that
even ACF formed by few crypts may carry dysplastic features
(Bird et al, 1989).
In rats treated with colon carcinogens, ACF are identified on the
basis of their atypical appearance against a background of normal
crypts (Bird, 1987) and used as such in short-term colon carcino-
genesis studies without considering their dysplasia. On the basis of
our results we suggest that in rat the formation of such ACF is an
event independent ofApc mutation.
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